Clear Dx

Clear Dx® is a fully automated next-generation sequencing (NGS) solution from Clear Labs, purpose-built for oncology research. The platform integrates sample preparation, sequencing, and bioinformatics into a single, seamless walkaway workflow, enabling research institutions to simplify targeted and comprehensive sequencing while advancing genomics with unmatched simplicity and scalability.

With over 100 systems deployed across leading laboratories, Clear Dx® is designed for research teams seeking to accelerate genomic applications in oncology without the complexity typically associated with NGS workflows. The solution is intended for research use only and is not for use in diagnostic procedures.

Core Capabilities

• Fully automated NGS workflow: Combines sample preparation, sequencing, and bioinformatics into one integrated, walkaway process, minimising manual intervention and reducing hands-on time.
• On-site sequencing: Enables institutions to run NGS directly within their own laboratory environment, supporting greater control and faster turnaround for research projects.
• Oncology-focused genomic solutions: Specifically designed to support targeted and comprehensive sequencing workflows relevant to oncology research applications.
• Scalable platform: Built to support institutions of varying sizes, with a growing installed base of over 100 systems across leading research laboratories.

Platform Design and Workflow

• Seamlessly integrates all major NGS steps — from sample preparation through to bioinformatics analysis — within a single automated system.
• Walkaway automation reduces the need for continuous operator involvement, freeing researchers to focus on data interpretation and scientific outcomes.
• Designed to empower institutions to advance genomics research with simplicity, enabling broader adoption of NGS technology across oncology research settings.

Clear Dx® is part of Clear Labs' broader portfolio of automated genomic solutions, which also spans infectious disease research and food safety testing. The platform is positioned for research institutions looking to bring robust, automated NGS capabilities on-site, supported by a proven and expanding network of deployed systems.